AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 39 filers reported holding AXCELLA HEALTH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,218,000 | -15.8% | 712,500 | 0.0% | 0.05% | -32.5% |
| Q2 2022 | $1,446,000 | -21.0% | 712,500 | 0.0% | 0.08% | 0.0% |
| Q1 2022 | $1,831,000 | +23.0% | 712,500 | 0.0% | 0.08% | +92.5% |
| Q4 2021 | $1,489,000 | -29.9% | 712,500 | 0.0% | 0.04% | -16.7% |
| Q3 2021 | $2,123,000 | -25.7% | 712,500 | 0.0% | 0.05% | -17.2% |
| Q2 2021 | $2,857,000 | -15.8% | 712,500 | 0.0% | 0.06% | -3.3% |
| Q1 2021 | $3,392,000 | -8.3% | 712,500 | 0.0% | 0.06% | -24.1% |
| Q4 2020 | $3,698,000 | +12.3% | 712,500 | 0.0% | 0.08% | -1.2% |
| Q3 2020 | $3,292,000 | -33.9% | 712,500 | -20.8% | 0.08% | -42.4% |
| Q2 2020 | $4,977,000 | +142.5% | 900,000 | +50.0% | 0.14% | +59.8% |
| Q1 2020 | $2,052,000 | +13.7% | 600,000 | +33.3% | 0.09% | +24.3% |
| Q4 2019 | $1,805,000 | -29.1% | 450,000 | 0.0% | 0.07% | -31.4% |
| Q3 2019 | $2,547,000 | -29.8% | 450,000 | +15.5% | 0.10% | -30.6% |
| Q2 2019 | $3,628,000 | – | 389,741 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 2,807,981 | $14,573,000 | 5.70% |
| Flagship Pioneering Inc. | 12,548,414 | $65,126,000 | 1.19% |
| Artal Group S.A. | 712,500 | $3,698,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 30,713 | $159,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 132,915 | $690,000 | 0.01% |
| Virtu Financial LLC | 15,682 | $81,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 187,122 | $971,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62,467 | $324,000 | 0.01% |
| FMR LLC | 5,631,132 | $29,226,000 | 0.00% |
| MARSHALL WACE, LLP | 60,307 | $313,000 | 0.00% |